AdaptHealth supplies home medical devices for diabetes, sleep apnea and wound care. Its common shares are listed on NASDAQ as AHCO. Lead Plaintiffs allege that, during the Settlement Class Period (August 4, 2020 through November 7, 2023), defendants made false or misleading statements concerning AdaptHealth’s billing methods; its compliance programs and related technology; the company’s capacity to fold acquisitions into existing compliance systems; and its reported revenues and EBITDA. Class Period: August 4, 2020 to February 2, 2024.